Rachel Vatnsdal
Stock Analyst at JP Morgan
(0.23)
# 2109
Out of 5,243 analysts
56
Total ratings
52.63%
Success rate
9.65%
Average return
Main Sectors:
Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
Agilent Technologies | Maintains: Overweight | 165 160 | 142.18 | 12.53% | 6 | Nov 26, 2024 | |
Waters | Maintains: Neutral | 340 380 | 397.49 | -4.4% | 3 | Nov 4, 2024 | |
10x Genomics | Maintains: Neutral | 20 14 | 14.98 | -6.54% | 2 | Oct 30, 2024 | |
Thermo Fisher Scient... | Maintains: Overweight | 650 670 | 551.61 | 21.46% | 8 | Sep 20, 2024 | |
Henry Schein | Maintains: Overweight | 88 80 | 71.14 | 12.45% | 3 | Aug 12, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 23 16 | 19.22 | -16.75% | 3 | Aug 8, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 42 47 | 34.88 | 34.75% | 2 | Aug 7, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underweight | 17 20 | 13.14 | 52.21% | 3 | Aug 7, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 2 | Aug 6, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 1300 1400 | 1279.28 | 9.44% | 2 | Aug 5, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 5 6 | 7.15 | -16.08% | 4 | Aug 2, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 190 200 | 157.12 | 27.29% | 4 | Jul 31, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 105 120 | 118.88 | 0.94% | 3 | Jul 30, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 1 | Apr 22, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Overweight | 60 90 | 57.65 | 56.11% | 2 | Feb 14, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 250 270 | 237.85 | 13.52% | 4 | Dec 20, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 1 | Nov 27, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 90 45 | n/a | n/a | 1 | May 22, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underweight | n/a | n/a | n/a | 2 | Nov 10, 2022 |